Literature DB >> 15138456

Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2.

Grzegorz M Burzynski1, Ilja M Nolte, Jan Osinga, Isabella Ceccherini, Bas Twigt, Saskia Maas, Alice Brooks, Joke Verheij, Ivan Plaza Menacho, Charles H C M Buys, Robert M W Hofstra.   

Abstract

Hirschsprung disease (HSCR), a congenital disorder characterized by intestinal obstruction due to absence of enteric ganglia along variable lengths of the intestinal tract, occurs both in familial and sporadic cases. RET mutations have been found in approximately 50% of the families, but explains only a minority of sporadic cases. This study aims at investigating a possible role of RET in sporadic HSCR patients. Haplotypes of 13 DNA markers, within and flanking RET, have been determined for 117 sporadic HSCR patients and their parents. Strong association was observed for six markers in the 5' region of RET. The largest distortions in allele transmission were found at the same markers. One single haplotype composed of these six markers was present in 55.6% of patients versus 16.2% of controls. Odds ratios (ORs) revealed a highly increased risk of homozygotes for this haplotype to develop HSCR (OR>20). These results allowed us to conclude that RET plays a crucial role in HSCR even when no RET mutations are found. An unknown functional disease variant(s) with a dosage-dependent effect in HSCR is likely located between the promoter region and exon 2 of RET.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138456     DOI: 10.1038/sj.ejhg.5201199

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

Review 1.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

Review 2.  Enteric nervous system development: A crest cell's journey from neural tube to colon.

Authors:  Nandor Nagy; Allan M Goldstein
Journal:  Semin Cell Dev Biol       Date:  2017-01-10       Impact factor: 7.727

3.  [Genetic bases of Hirschsprung's disease].

Authors:  E Passarge; E Bruder
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

4.  RET polymorphisms and the risk of Hirschsprung's disease in a Chinese population.

Authors:  Cuiping Liu; Lei Jin; Hui Li; Jintu Lou; Chunfen Luo; Xuewu Zhou; Ji-Cheng Li
Journal:  J Hum Genet       Date:  2008-07-08       Impact factor: 3.172

Review 5.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

Review 6.  Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.

Authors:  S W Moore; M G Zaahl
Journal:  Pediatr Surg Int       Date:  2008-03-26       Impact factor: 1.827

7.  A novel susceptibility locus for Hirschsprung's disease maps to 4q31.3-q32.3.

Authors:  A S Brooks; P A Leegwater; G M Burzynski; P J Willems; B de Graaf; I van Langen; P Heutink; B A Oostra; R M W Hofstra; A M Bertoli-Avella
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

8.  Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease in Taiwan.

Authors:  Trang-Tiau Wu; Tsui-Wei Tsai; Chao-Ta Chu; Zen-Fung Lee; Chuan-Mao Hung; Ching-Chyuan Su; Shuan-Yow Li; Mingli Hsieh; Chuan Li
Journal:  J Hum Genet       Date:  2005-04-15       Impact factor: 3.172

9.  Identifying candidate Hirschsprung disease-associated RET variants.

Authors:  Grzegorz M Burzynski; Ilja M Nolte; Agnes Bronda; Krista K Bos; Jan Osinga; Ivan Plaza Menacho; Bas Twigt; Saskia Maas; Alice S Brooks; Joke B G M Verheij; Charles H C M Buys; Robert M W Hofstra
Journal:  Am J Hum Genet       Date:  2005-03-09       Impact factor: 11.025

10.  Fine mapping of the 9q31 Hirschsprung's disease locus.

Authors:  C S Tang; Y Sribudiani; X P Miao; A R de Vries; G Burzynski; M T So; Y Y Leon; B H Yip; J Osinga; K J W S Hui; J B G M Verheij; S S Cherny; P K H Tam; P C Sham; R M W Hofstra; M M Garcia-Barceló
Journal:  Hum Genet       Date:  2010-04-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.